Handayani, Wahyu (2022) ANALISIS PENGARUH COLLATERALIZABLE ASSETS, FREE CAS FLOW, INVESTMENT OPPORTUNITY SET, LEVERAGE DAN PROFITABILITAS TERHADAP KEBIJAKAN DIVIDEN PADA PERUSAHAAN MANUFAKTUR SUBSEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE 2018-2020. Skripsi (S1) thesis, Universitas Muhammadiyah Ponorogo.
![[img]](http://eprints.umpo.ac.id/style/images/fileicons/text.png) |
Text (Surat Persetujuan Unggah Karya Ilmiah)
Surat Persetujuan Unggah Karya Ilmiah.pdf Download (193kB) |
|
Text (Halaman Depan)
halaman depan.pdf Download (656kB) |
|
Text (BAB I)
BAB I.pdf Download (287kB) |
|
Text (BAB II)
BAB II.pdf Restricted to Registered users only Download (499kB) |
|
Text (BAB III)
BAB III.pdf Restricted to Registered users only Download (362kB) |
|
Text (BAB IV)
BAB IV.pdf Restricted to Registered users only Download (365kB) |
|
Text (BAB V)
BAB V.pdf Restricted to Registered users only Download (183kB) |
|
Text (Daftar Pustaka)
Daftar Pustaka.pdf Download (329kB) |
|
Text (Lampiran)
Lampiran.pdf Download (714kB) |
|
Text (Skripsi Full Text)
full skripsi.pdf Restricted to Repository staff only Download (1MB) |
Abstract
SUMMARY This study aims to examine the effect of collateralizable assets, free cash flow, investment opportunity set, leverage, and profitability on the dividend policy of pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange for the 2018-2020 period. This research uses quantitative research. The source of data in this study is using secondary data. The object of this research was conducted on pharmaceutical companies listed on the Indonesia Stock Exchange in 2018-2020. The sampling method used is saturated sampling. The population in this study are pharmaceutical companies listed on the Indonesia Stock Exchange (IDX) and published financial statements for the 2018-2020 period, totaling 10 companies, with a 3-year study the author examined 30 data. The results of testing the first hypothesis indicate that the collateralizable asset variable has no effect on dividend policy, this proves that the lower the collateralizable asset, the lower the dividend payment. Testing the second hypothesis shows that the free cash flow variable has no effect on dividend policy, this proves that the high and low free cash flow of the company does not guarantee that the company pays dividends but prefers to increase the company's capital. The third hypothesis shows that the investment opportunity set variable has no effect on dividend policy, this proves that if the company has a high investment opportunity set, the distribution of dividends to shareholders will be lower. The fourth hypothesis shows that the leverage variable has an effect on dividend policy, this proves that the lower the leverage owned by the company, the higher the amount of dividends that will be distributed by the company. The fifth hypothesis shows that profitability has an effect on dividend policy, which means that companies with high profitability pay out dividends as well. The sixth hypothesis shows that collateralizable assets, free cash flow, investment opportunity set, leverage, profitability have a simultaneous effect on dividend policy. Keywords: Pharmaceutical Company, Dividend Per Share, Collateralizable Assets, Free Cash Flow, Investment Opportunity Set, Leverage, Profitability.
| Item Type: | Thesis (Skripsi (S1)) |
|---|---|
| Uncontrolled Keywords: | Keywords: Pharmaceutical Company, Dividend Per Share, Collateralizable Assets, Free Cash Flow, Investment Opportunity Set, Leverage, Profitability. |
| Subjects: | H Social Sciences > HG Finance |
| Divisions: | Faculty of Economic > Department of Accounting |
| Depositing User: | fe . userfe |
| Date Deposited: | 16 Aug 2022 04:55 |
| Last Modified: | 16 Aug 2022 04:55 |
| URI: | http://eprints.umpo.ac.id/id/eprint/9556 |
Actions (login required)
 |
View Item |
